TF
BMY.RT

TimeScale Financial’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

TimeScale Financial’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-930
Closed -$1K – 545
2020
Q4 		$1K Sell
930
-44
-5% -$94 ﹤0.01% 422
2020
Q3 		$3K Buy
+974
New +$2.78K ﹤0.01% 393

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

TimeScale Financial's BMY.RT Position: Q1 2021 in Review

TimeScale Financial sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 930 shares — an estimated $1K sold.

TimeScale Financial first reported a position in BMY.RT in Q3 2020 and held it in 2 quarters. The position peaked at $3K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • TimeScale Financial reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • TimeScale Financial sold 930 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1K.
  • TimeScale Financial first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q3 2020 and held it in 2 quarters.
  • TimeScale Financial's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $3K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on TimeScale Financial's 13F filing for Q1 2021, filed 22 Apr 2021.